![logo](/logos/EBS.webp)
Emergent BioSolutions Inc.
NYSE:EBS
7.52 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Emergent BioSolutions Inc. |
Symbool | EBS |
Munteenheid | USD |
Prijs | 7.52 |
Beurswaarde | 397,857,632 |
Dividendpercentage | 0% |
52-weken bereik | 1.42 - 15.1 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Richard S. Lindahl M.B.A. |
Website | https://www.emergentbiosolutions.com |
An error occurred while fetching data.
Over Emergent BioSolutions Inc.
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)